Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results
27 août 2020 09h00 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced with its...
Akers Biosciences and Premas Biotech Announce Initiation of Animal Studies
07 juil. 2020 09h00 HE
|
Akers Biosciences Inc.
Company intends to cease focus on screening and testing products business Thorofare, New Jersey, July 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a...